ACT Genomics

About:

ACT Genomics is a cancer molecular information service company teamed up with experts with multiple years’ experience in oncology

Website: http://www.actgenomics.com/

Top Investors: Hong Kong Science and Technology Parks Corporation, Kyoto University Innovation Capital, CLSA Capital Partners, CDIB Capital, Aflac Global Ventures

Description:

ACT Genomics is a cancer molecular information service company teamed up with experts with multiple years’ experience in oncology, cancer genomics, and bioinformatics. The company’s technology provides the possibility to transform cancer genomic information into precision diagnosis and personalized treatments. Every patient’s cancer is unique at the molecular level. Specific genetic alterations drive the pathogenesis and determine the treatment response of individual tumor. Understanding the genetic alteration helps to design a more effective treatment strategy and provide a more accurate prediction for patient’s outcome. The use of genomics is changing the paradigm of oncology treatment decisions and making great impacts on personalized treatment. Such comprehensive tumor profiling is now affordable due to rapid progress in sequencing and informatics technologies.